XenoPort (XNPT)

Add to Watchlists
Create an Alert
4.20 +0.02  +0.48% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
XNPT Price Chart
View All Events

XNPT Events

Date Type Description
Feb 20 Misc Q4 2013 Xenoport Earnings Conference Call
Feb 20 Earnings Q4 2013 Xenoport Earnings Results. Estimate: -0.44.
Nov 07 Misc Q3 2013 XenoPort, Inc. Earnings Conference Call
Nov 07 Earnings Xenoport to Release Third Quarter Financial Results on November 7. Estimate: -0.49.
Aug 06 Misc Q2 2013 XenoPort, Inc. Earnings Conference Call
Aug 06 Earnings Xenoport to Release Second Quarter Financial Results on August 6. Estimate: -0.52.
May 14 Misc AGM Event for Xenoport Inc
Apr 24 Misc Q1 2013 XenoPort, Inc. Earnings Conference Call
Apr 24 Earnings Xenoport to Release First Quarter Financial Results on April 24. Estimate: -0.43.
View All Performance Charts

XNPT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). XenoPort is down 40.30% over the last year vs S&P 500 Total Return up 20.96%, Actelion up 66.30%, and Jazz Pharmaceuticals up 157.9%.

Get Quote for
Advertisement

Portfolio Strategies Featuring XNPT

Did XenoPort make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

XNPT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

XenoPort, Inc., is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates with an initial focus on neurological disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
XNPT 4.20 +0.02 +0.48% 252.02M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.